Market Tracker

04/27 5:16pm ET

United Therapeutics Corp (NASDAQ:UTHR)

120.50
Delayed Data
As of 3:59pm ET
 +0.51 / +0.43%
Today’s Change
97.52
Today|||52-Week Range
169.89
-15.99%
Year-to-Date
United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss
12:07pm / Zacks.com - Paid Partner Content
5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates
Apr 17 / Zacks.com - Paid Partner Content
Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More
Apr 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close119.99
Today’s open120.72
Day’s range119.80 - 121.26
Volume950,442
Average volume (3 months)643,139
Market cap$5.4B
Dividend yield--
Data as of 3:59pm ET, 04/27/2017

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-15.90%
Earnings growth (next 5 years)-6.70%
Revenue growth (last year)+9.08%
P/E ratio7.9
Price/Sales4.20
Price/Book2.78

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.06+0.28%
IONSIonis Pharmaceutical...+0.60+1.28%
TAROTaro Pharmaceutical ...-1.40-1.19%
MNKMallinckrodt Plc+0.19+0.41%
Data as of 4:02pm ET, 04/27/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)$3.46
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts